{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:26:52Z","timestamp":1770413212659,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/bjc.2015.345","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T20:03:49Z","timestamp":1444766629000},"page":"1158-1167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol"],"prefix":"10.1038","volume":"113","author":[{"given":"Yu-chi","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Upadhyayula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Cevallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J","family":"Messick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew P","family":"Leese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas M","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daysha","family":"Ferrer-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese M","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Dohle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry V L","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate F","family":"Barald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,13]]},"reference":[{"key":"BFbjc2015345_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10162-005-0013-8","volume":"6","author":"LM Bianchi","year":"2005","unstructured":"Bianchi LM, Daruwalla Z, Roth TM, Attia NP, Lukacs NW, Richards AL, White IO, Allen SJ, Barald KF (2005) Immortalized mouse inner ear cell lines demonstrate a role for chemokines in promoting the growth of developing statoacoustic ganglion neurons. J Assoc Res Otolaryngol 6: 355\u2013367.","journal-title":"J Assoc Res Otolaryngol"},{"key":"BFbjc2015345_CR2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10637-010-9618-9","volume":"30","author":"JY Bruce","year":"2012","unstructured":"Bruce JY, Eickhoff J, Pili R, Logan T, Carducci M, Arnott J, Treston A, Wilding G, Liu G (2012) A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate. Invest New Drugs 30: 794\u2013802.","journal-title":"Invest New Drugs"},{"key":"BFbjc2015345_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.119.4.893","volume":"119","author":"K Burridge","year":"1992","unstructured":"Burridge K, Turner CE, Romer LH (1992) Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 119: 893\u2013903.","journal-title":"J Cell Biol"},{"key":"BFbjc2015345_CR4","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/sj.bjc.6603727","volume":"96","author":"SK Chander","year":"2007","unstructured":"Chander SK, Foster PA, Leese MP, Newman SP, Potter BVL, Purohit A, Reed MJ (2007) In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol. Br J Cancer 96: 1368\u20131376.","journal-title":"Br J Cancer"},{"key":"BFbjc2015345_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/sj.bjc.6604873","volume":"100","author":"JM Day","year":"2009","unstructured":"Day JM, Foster PA, Tutill HJ, Newman SP, Ho YT, Leese MP, Potter BVL, Reed MJ, Purohit A (2009) BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure. Br J Cancer 100: 476\u2013486.","journal-title":"Br J Cancer"},{"key":"BFbjc2015345_CR6","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/cmdc.201300412","volume":"9","author":"W Dohle","year":"2014","unstructured":"Dohle W, Leese MP, Jourdan FL, Chapman CJ, Hamel E, Ferrandis E, Potter BVL (2014) Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors. ChemMedChem 9: 1783\u20131793.","journal-title":"ChemMedChem"},{"key":"BFbjc2015345_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ceb.2004.09.011","volume":"16","author":"AL Edinger","year":"2004","unstructured":"Edinger AL, Thompson CB (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16: 663\u2013669.","journal-title":"Curr Opin Cell Biol"},{"key":"BFbjc2015345_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev-cellbio-101011-155711","volume":"29","author":"S Etienne-Manneville","year":"2013","unstructured":"Etienne-Manneville S (2013) Microtubules in cell migration. Annu Rev Cell Dev Biol 29: 471\u2013499.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFbjc2015345_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10549-007-9791-5","volume":"111","author":"PA Foster","year":"2008","unstructured":"Foster PA, Ho YT, Newman SP, Kasprzyk PG, Leese MP, Potter BVL, Reed MJ, Purohit A (2008) 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Res Treat 111: 251\u2013260.","journal-title":"Breast Cancer Res Treat"},{"key":"BFbjc2015345_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2004.01.006","volume":"16","author":"S Frahm","year":"2004","unstructured":"Frahm S, Mautner VF, Brems H, Legius E, Debiec-Rychter M, Friedrich RE, Kn\u00f6fel WT, Peiper M, Kluwe L (2004) Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients. Neurobiol Dis 16: 85\u201391.","journal-title":"Neurobiol Dis"},{"key":"BFbjc2015345_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA (2009) Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4: 309\u2013324.","journal-title":"Nat Protoc"},{"key":"BFbjc2015345_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1158\/1078-0432.CCR-08-1389","volume":"15","author":"M Ganapathy","year":"2009","unstructured":"Ganapathy M, Ghosh R, Jianping X, Zhang X, Bedolla R, Schoolfield J, Yeh IT, Troyer DA, Olumi AF, Kumar AP (2009) Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouseprostate model. Clin Cancer Res 15: 1601\u20131611.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015345_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1158\/1078-0432.CCR-05-2068","volume":"12","author":"GE Garcia","year":"2006","unstructured":"Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP (2006) 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6. Clin Cancer Res 12: 980\u2013988.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015345_CR14","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2009.11.FOCUS09221","volume":"28","author":"ON Gottfried","year":"2010","unstructured":"Gottfried ON, Viskochil DH, Couldwell WT (2010) Neurofibromatosis type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Neurosurg Focus 28: E8.","journal-title":"Neurosurg Focus"},{"key":"BFbjc2015345_CR15","doi-asserted-by":"publisher","first-page":"29960","DOI":"10.1074\/jbc.274.42.29960","volume":"274","author":"MJ Grossel","year":"1999","unstructured":"Grossel MJ, Baker GL, Hinds PW (1999) cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain. J Biol Chem 274: 29960\u201329967.","journal-title":"J Biol Chem"},{"key":"BFbjc2015345_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/sj.bjc.6601591","volume":"90","author":"CR Ireson","year":"2004","unstructured":"Ireson CR, Chander SK, Purohit A, Parish DC, Woo LW, Potter BVL, Reed MJ (2004) Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 90: 932\u2013937.","journal-title":"Br J Cancer"},{"key":"BFbjc2015345_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1172\/JCI60578","volume":"123","author":"WJ Jessen","year":"2013","unstructured":"Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N (2013) MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. J Clin Invest 123: 340\u2013347.","journal-title":"J Clin Invest"},{"key":"BFbjc2015345_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12: 1\u201311.","journal-title":"Genet Med"},{"key":"BFbjc2015345_CR19","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/1535-7163.MCT-07-2335","volume":"7","author":"G Johansson","year":"2008","unstructured":"Johansson G, Mahller YY, Collins MH, Kim MO, Nobukuni T, Perentesis J, Cripe TP, Lane HA, Kozma SC, Thomas G, Ratner N (2008) Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. Mol Cancer Ther 7: 1237\u20131245.","journal-title":"Mol Cancer Ther"},{"key":"BFbjc2015345_CR20","doi-asserted-by":"publisher","first-page":"25985","DOI":"10.1074\/jbc.270.43.25985","volume":"270","author":"R Kapeller","year":"1995","unstructured":"Kapeller R, Toker A, Cantley LC, Carpenter CL (1995) Phosphoinositide 3-kinase binds constitutively to alpha\/beta-tubulin and binds to gamma-tubulin in response to insulin. J Biol Chem 270: 25985\u201325991.","journal-title":"J Biol Chem"},{"key":"BFbjc2015345_CR21","first-page":"142","volume-title":"Neurofibromatosis","author":"BR Korf","year":"1999","unstructured":"Korf BR (1999) Neurofibromas and Malignant Tumors of the Peripheral Nerve Sheath. In JM Friedman, eds Neurofibromatosis 3rd edition The Johns Hopkins University Press: Baltimore, MD, USA, pp 142\u2013161."},{"key":"BFbjc2015345_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/59.9.759","volume":"59","author":"N Lau","year":"2000","unstructured":"Lau N, Feldkamp MM, Roncari L, Loehr AH, Shannon P, Gutmann DH, Guha A (2000) Loss of neurofibromin is associated with activation of RAS\/MAPK and PI3-K\/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol 59: 759\u2013767.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFbjc2015345_CR23","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1039\/c002558e","volume":"46","author":"MP Leese","year":"2010","unstructured":"Leese MP, Jourdan F, Kimberley MR, Cozier GE, Thiyagarajan N, Stengel C, Regis-Lydi S, Foster PA, Newman SP, Acharya KR, Ferrandis E, Purohit A, Reed MJ, Potter BVL (2010) Chimeric microtubule disruptors. Chem Comm 46: 2907\u20132909.","journal-title":"Chem Comm"},{"key":"BFbjc2015345_CR24","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1021\/jm060705x","volume":"49","author":"MP Leese","year":"2006","unstructured":"Leese MP, LeBlond B, Smith A, Newman SP, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL (2006) 2-Substituted estradiol bis-sulfamates, multi-targeted anti-tumor agents: Synthesis, in vitro SAR, protein crystallography and in vivo activity. J Med Chem 49: 7683\u20137696.","journal-title":"J Med Chem"},{"key":"BFbjc2015345_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4161\/cbt.10.8.12878","volume":"10","author":"H Li","year":"2010","unstructured":"Li H, Zhang X, Fishbein L, Kweh F, Campbell-Thompson M, Perrin GQ, Muir D, Wallace M (2010) Analysis of steroid hormone effects on xenografted human NF1 tumor Schwann cells. Cancer Biol Ther 10: 758\u2013764.","journal-title":"Cancer Biol Ther"},{"key":"BFbjc2015345_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0163-7258(91)90027-J","volume":"49","author":"RF Luduena","year":"1991","unstructured":"Luduena RF, Roach MC (1991) Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents. Pharmacol Ther 49: 133\u2013152.","journal-title":"Pharmacol Ther"},{"key":"BFbjc2015345_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","volume":"3","author":"NJ Mabjeesh","year":"2003","unstructured":"Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3: 363\u2013375.","journal-title":"Cancer Cell"},{"key":"BFbjc2015345_CR28","first-page":"5441","volume":"60","author":"L MacCarthy-Morrogh","year":"2000","unstructured":"MacCarthy-Morrogh L, Townsend PA, Purohit A, Hejaz HAM, Potter BVL, Reed MJ, Packham G (2000) Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells. Cancer Res 60: 5441\u20135450.","journal-title":"Cancer Res"},{"key":"BFbjc2015345_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20110892","volume":"441","author":"B Magnuson","year":"2012","unstructured":"Magnuson B, Ekim B, Fingar DC (2012) Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 441: 1\u201321.","journal-title":"Biochem J"},{"key":"BFbjc2015345_CR30","first-page":"752","volume":"63","author":"ME McLaughlin","year":"2003","unstructured":"McLaughlin ME, Jacks T (2003) Progesterone receptor expression in neurofibromas. Cancer Res 63: 752\u2013755.","journal-title":"Cancer Res"},{"key":"BFbjc2015345_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejcb.2012.12.002","volume":"92","author":"CT Mierke","year":"2013","unstructured":"Mierke CT (2013) Physical break-down of the classical view on cancer cell invasion and metastasis. Eur J Cell Biol 92: 89\u2013104.","journal-title":"Eur J Cell Biol"},{"key":"BFbjc2015345_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1158\/1078-0432.CCR-07-1717","volume":"14","author":"SP Newman","year":"2008","unstructured":"Newman SP, Foster PA, Stengel C, Day JM, Ho YT, Judde JG, Lassalle M, Prevost G, Leese MP, Potter BVL, Reed MJ, Purohit A (2008) STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells. Clin Cancer Res 14: 597\u2013606.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015345_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1471-2407-13-224","volume":"13","author":"J Ohishi","year":"2013","unstructured":"Ohishi J, Aoki M, Nabeshima K, Suzumiya J, Takeuchi T, Ogose A, Hakozaki M, Yamashita Y, Iwasaki H (2013) Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-\u03b2. BMC Cancer 13: 224.","journal-title":"BMC Cancer"},{"key":"BFbjc2015345_CR34","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1175862","volume":"326","author":"TD Pollard","year":"2009","unstructured":"Pollard TD, Cooper JA (2009) Actin, a central player in cell shape and movement. Science 326: 1208\u20131212.","journal-title":"Science"},{"key":"BFbjc2015345_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0960-0760(97)00196-9","volume":"64","author":"A Purohit","year":"1998","unstructured":"Purohit A, Vernon KA, Hummelinck AE, Woo LW, Hejaz HA, Potter BVL, Reed MJ (1998) The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity. J Steroid Biochem Mol Biol 64: 269\u2013275.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFbjc2015345_CR36","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1006\/bbrc.2001.5320","volume":"285","author":"LR Qadan","year":"2001","unstructured":"Qadan LR, Perez-Stable CM, Anderson C, D'Ippolito G, Herron A, Howard GA, Roos BA (2001) 2-Methoxyestradiol induces G2\/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun 285: 1259\u20131266.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFbjc2015345_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/glia.20534","volume":"55","author":"TM Roth","year":"2007","unstructured":"Roth TM, Ramamurthy P, Ebisu F, Lisak RP, Bealmear BM, Barald KF (2007) A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation. Glia 55: 1123\u20131133.","journal-title":"Glia"},{"key":"BFbjc2015345_CR38","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ajmg.a.32301","volume":"146A","author":"TM Roth","year":"2008","unstructured":"Roth TM, Petty EM, Barald KF (2008a) The role of steroid hormones in the NF1 phenotype: focus on pregnancy. Am J Med Genet A 146A: 1624\u20131633.","journal-title":"Am J Med Genet A"},{"key":"BFbjc2015345_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/dvdy.21430","volume":"237","author":"TM Roth","year":"2008","unstructured":"Roth TM, Ramamurthy P, Muir D, Wallace M, Zhu Y, Chang L, Barald KF (2008b) Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin. Dev Dyn 237: 513\u2013524.","journal-title":"Dev Dyn"},{"key":"BFbjc2015345_CR40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1096\/fj.01-0995fje","volume":"16","author":"G Shaw","year":"2002","unstructured":"Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16: 869\u2013871.","journal-title":"FASEB J"},{"key":"BFbjc2015345_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/sj.bjc.6605489","volume":"102","author":"C Stengel","year":"2010","unstructured":"Stengel C, Newman SP, Leese MP, Potter BVL, Reed MJ, Purohit A (2010) Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents. Br J Cancer 102: 316\u2013324.","journal-title":"Br J Cancer"},{"key":"BFbjc2015345_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/bjc.2014.188","volume":"111","author":"C Stengel","year":"2014","unstructured":"Stengel C, Newman SP, Foster PA, Chander SK, Leese MP, Potter BVL, Reed MJ, Purohit A, Foster PA (2014) In vitro and in vivo properties of STX2484: a nonsteroidal anticancer compound active in taxane-resistant cells. Brit J Cancer 111: 300\u2013308.","journal-title":"Brit J Cancer"},{"key":"BFbjc2015345_CR43","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/sj.bjc.6604752","volume":"99","author":"SL Tagg","year":"2008","unstructured":"Tagg SL, Foster PA, Leese MP, Potter BVL, Reed MJ, Purohit A, Newman SP (2008) 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer. Br J Cancer 99: 1842\u20131848.","journal-title":"Br J Cancer"},{"key":"BFbjc2015345_CR44","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2741\/3727","volume":"16","author":"M Upadhyaya","year":"2011","unstructured":"Upadhyaya M (2011) Genetic basis of tumorigenesis in NF1malignant peripheral nerve sheath tumors. Front Biosci 16: 937\u2013951.","journal-title":"Front Biosci"},{"key":"BFbjc2015345_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.2134734","volume":"249","author":"MR Wallace","year":"1990","unstructured":"Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249: 181\u2013186.","journal-title":"Science"},{"key":"BFbjc2015345_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599\u2013608.","journal-title":"Cell"},{"key":"BFbjc2015345_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1750-1172-8-127","volume":"8","author":"O Zehou","year":"2013","unstructured":"Zehou O, Fabre E, Zelek L, Sbidian E, Ortonne N, Banu E, Wolkenstein P, Valeyrie-Allanore L (2013) Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review. Orphanet J Rare Dis 8: 127.","journal-title":"Orphanet J Rare Dis"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2015345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015345","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:30:33Z","timestamp":1684416633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2015345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFbjc2015345"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2015.345","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"19 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no scientific or financial conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}